1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
A short peptide of the C-terminal class Y helices of apolipoprotein A-I has preserved functions in cholesterol efflux and in vivo metabolic control
(
- Contribution to journal › Article
- 2019
-
Mark
ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice
(
- Contribution to journal › Article
- 2016
-
Mark
Dual actions of apolipoprotein A-I on glucose-stimulated insulin secretion and insulin-independent peripheral tissue glucose uptake lead to increased heart and skeletal muscle glucose disposal
(
- Contribution to journal › Article
- 2015
-
Mark
ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP/PKA activation.
(
- Contribution to journal › Article
- 2014
-
Mark
Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility.
(
- Contribution to journal › Article
-
Mark
Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice.
(
- Contribution to journal › Article
-
Mark
APOLIPOPROTEIN A-I DERIVED PEPTIDES FOR TREATMENT OF HYPERGLYCAEMIA
2014) 019-094-625-110-905(
- Patent › Patent
- 2013
-
Mark
Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle.
(
- Contribution to journal › Article